The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion

Biochemical and Biophysical Research Communications

Volumn 232, Issue 1, 1997, Pages 42-48

  Jorquera, Rossana ^a   Tanguay, Robert M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; FUMARYLACETOACETASE; FUMARYLACETOACETATE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE MUTATION; LIVER DISEASE; METABOLITE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; TYROSINEMIA;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031555866     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6220     Document Type: Article

References (29)

1. Lindblad B., Lindstedt S., Steen G. Proc. Natl. Acad. Sci. USA. 74:1977;4641-4645.
2. Tanguay R. M., Valet J. P., Lescault A., Duband J. L., Laberge C., Lettre F., Plante M. Am. J. Hum. Genet. 47:1990;308-316.
3. Phaneuf D., Lambert M., Laframboise R., Mitchell G., Lettre F., Tanguay R. M. J. Clin. Invest. 90:1992;1185-1192.
4. G. A. Mitchell, M. Lambert, R. M. Tanguay, 1995, The Metabolic and Molecular Bases of Inherited Disease, 1077, 1106, McGraw-Hill, New York.
5. Weinberg A. G., Mize C. E., Worthen H. G. J. Pediatr. 88:1976;434-438.
6. Stoner E., Starkman H., Wellner D., Wellner V. P., Sassa S., Rifkind A. B., Grenier A., Steinherz P. G., Meister A., New M. I., Levine L. S. Pediatr. Res. 18:1985;1332-1336.
7. C. Laberge, A. Lescault, R. M. Tanguay, 1986, Essential Nutrients in Carcinogenesis, L. A. PoirierP. M. NewberneM. W. Pariza, 209, 221, Plenum, New York.
8. Tanguay R. M., Jorquera R., Poudrier J., St-Louis M. Acta Biochim. Polon. 43:1996;209-216.
9. Manabe S., Sassa S., Kappas A. J. Exp. Med. 162:1985;1060-1074.
10. Edwards S. W., Knox W. E. Methods Enzymol. 2:1955;292-300.
11. Bradley M. O., Sharkey N. A., Kohn K. W., Layard M. W. Cancer Res. 40:1980;2719-2725.
12. Glatt H. Mutation Res. 238:1990;235-243.
13. Rosenkranz A. R., Schmaldienst S., Stuhlmeier K. M., Chen W., Knapp W., Zlabinger G. J. J. Immunol. Methods. 156:1992;39-45.
14. Thioudellet C., Oster T., Leroy P., Nicolas A., Wellman M. Cell Biol. Toxicol. 11:1995;103-111.
15. Suzukake K., Petro B. J., Vistica D. T. Biochem. Pharmacol. 31:1982;121-124.
16. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. J. Biol. Chem. 193:1951;265-275.
17. Griffith O. W. Methods Enzymol. 77:1981;59-63.
18. Boyland E., Chasseaud L. F. Biochem. J. 104:1967;95-102.
19. Wellner V. P., Anderson M. E., Puri R. N., Jensen G. L., Meister A. Proc. Natl. Acad. Sci. USA. 81:1984;4732-4735.
20. Cerutti P. A., Trump B. F. Cancer Cells. 3:1991;1-7.
21. Edwards S. W., Knox W. E. J. Biol. Chem. 220:1956;79-91.
22. Plummer J. L., Smith B. R., Sies H., Bend J. R. Methods Enzymol. 77:1981;50-59.
23. Deneke S. M., Fanburg B. L. Am. J. Physiol. 257:1989;L163-L173.
24. Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. J. Pharmacol. Exp. Ther. 187:1973;211-217.
25. Jansen J. G., Vrieling H., van Zeeland A. A., Mohn G. R. Mutation Res. 266:1992;105-116.
26. Held K. D., Epp E. R., Awad S., Biaglow J. E. Radiat. Res. 127:1991;75-80.
27. Lloyd A. J., Gray R. G. F., Green A. J. Inher. Metab. Dis. 18:1995;48-55.
28. Gilbert-Barness E., Barness L. A., Meisner L. F. Pediatr. Pathol. 10:1990;243-252.
29. Edgren M., Revesz L., Larsson A. Int. J. Radiat. Biol. 40:1981;355-363.